Selection for hepatic resection: Expert consensus conference

HPB

Volumn 15, Issue 2, 2013, Pages 104-105

  Rees, Myrddin ^a   Elias, Dominique ^b   Coimbra, Felipe J F ^c   Orloff, Susan L ^d  

^a BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; HUMAN; LIVER METASTASIS; LIVER RESECTION; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PERITONEAL CARCINOMATOSIS; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL;

EID: 84872198144     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00568.x     Document Type: Note

References (10)

1. Fortner JG, Silva JS, Golbey RB, Gallowitz H, Maclean BJ,. (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199: 306-316. (Pubitemid 14194076)
2. Adson MA, Van Heerden JA,. (1980) Major hepatic resections for metastatic colorectal cancer. Ann Surg 191: 576-583. (Pubitemid 10107337)
3. Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, et al. (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 11: 38-47.
4. Swan PJ, Welsh FK, Chandrakumaran K, Rees M,. (2011) Long-term survival following delayed presentation and resection of colorectal liver metastases. Br J Surg 98: 1309-1317.
5. Knowles B, Welsh FK, Chandrakumaran K, John TG, Rees M,. (2012) Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy. HPB 14: 298-309.
6. Elias D, Sideris L, Pocard M, Ouellet JF, Boige V, Lasser P, et al. (2004) Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 11: 274-280. (Pubitemid 40486767)
7. Cresswell A, Welsh F, Chandrakumaran K, John TG, Rees M,. (2011) Can patients benefit from resection of colorectal liver metastases in the face of synchronous extra-hepatic disease? Br J Surg 98 (S7): 4-5.
8. Maggiori L, Elias D,. (2010) Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends. Eur J Surg Oncol 36: 599-603.
9. Roviello F, Caruso S, Marrelli D, Pedrazzani C, Neri A, De Stefano A, et al. (2011) Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol 20: e38-e54.
10. Adson MA,. (1987) Resection of liver metastases-when is it worthwhile? World J Surg 11: 511-520.